MCCP
MIRM icon

Mission Creek Capital Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Mission Creek Capital Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,315
Closed -$482K – 242
2023
Q4 		$482K Buy
+16,315
New +$494K 0.12% 155

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mission Creek Capital Partners's MIRM Position: Q1 2024 in Review

Mission Creek Capital Partners sold out of Mirum Pharmaceuticals (MIRM) in Q1 2024, closing a stake of 16,315 shares — an estimated $482K sold.

Mission Creek Capital Partners first reported a position in MIRM in Q4 2023 and held it in 1 quarter. The position peaked at $482K in Q4 2023. 172 funds tracked by Wall St. Rank hold MIRM as of Q1 2024.

  • Mission Creek Capital Partners reported no remaining Mirum Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Mission Creek Capital Partners sold 16,315 Mirum Pharmaceuticals shares in Q1 2024, an estimated $482K.
  • Mission Creek Capital Partners first reported a position in Mirum Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Mission Creek Capital Partners's Mirum Pharmaceuticals position peaked at $482K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2024.

Based on Mission Creek Capital Partners's 13F filing for Q1 2024, filed 14 May 2024.